Skip to content

Prognosis and Risk Factors for Acute Kidney Injury

Analysis for Prognosis and Risk Factors for Acute Kidney Injury: Multi-center Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06898944
Enrollment
320000
Registered
2025-03-27
Start date
2022-08-22
Completion date
2026-12-31
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Brief summary

The aim of our study is to analyze the accurate diagnosis and prognosis of acute kidney injury (AKI) based on its severity and to define long-term clinical and socioeconomic outcomes. Investigators defined the AKI group among adults aged 20 years or older who visited enrolled center and underwent at least two blood tests, including serum creatinine, within an interval of 7 days or less and a control group was matched 1:1 to the AKI group based on age, sex, year of visit, and baseline kidney function, forming the study population. Investigators then collected and analyzed various clinical, laboratory, and hospitalization records including demographic data, anthropometric data, laboratory data, and medical history.

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
CollaboratorOTHER
SMG-SNU Boramae Medical Center
CollaboratorOTHER
Keimyung University Dongsan Medical Center
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults over 20 years old who visited Parcitipating Medical Center (Seoul National University Hospital, Bundang Seoul National University Hospital, SMG-SNU Boramae Medical Center, Keimyung University Dongsan Medical Center) between 2006 and 2021 * The AKI group is defined as individuals meeting the AKI diagnostic criteria of the KDIGO Guideline (an increase in serum creatinine of ≥0.3 mg/dL or ≥1.5 times the baseline level) is enrolled. * The Control Group is defined as individuals from the study population who do not meet the AKI criteria and are matched 1:1 based on age, sex, year of visit, and baseline renal function.

Exclusion criteria

* Individuals under 20 years old * Individuals who did not undergo serum creatinine tests meeting the criteria * Individuals with pre-existing end-stage kidney disease (ESKD) who have undergone dialysis or kidney transplantation

Design outcomes

Primary

MeasureTime frame
Change from Baseline in Serum CreatinineFrom Index Date(The Date Which Acute Kidney Injury Occured) Through 5 Years After The Index Date

Secondary

MeasureTime frame
Change from Baseline in Urine Protein/Creatinine RatioFrom Index Date(The Date Which Acute Kidney Injury Occured) Through 5 Years After The Index Date
Incidence of Receiving Renal Replacement TherapyFrom Index Date(The Date Which Acute Kidney Injury Occured) Through 5 Years After The Index Date
Change from Baseline in Serum Hemogloblin LevelFrom Index Date(The Date Which Acute Kidney Injury Occured) Through 5 Years After The Index Date
Change from Baseline in Serum Albumin LevelFrom Index Date(The Date Which Acute Kidney Injury Occured) Through 5 Years After The Index Date

Countries

South Korea

Contacts

Primary ContactSehoon Park, M.D. Ph.D.
mailofsehoon@gmail.com+82-02-2072-4070
Backup ContactJin Kyung Kwon, M.D.
jkk1456@naver.com+82-02-2072-4070

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026